Related references
Note: Only part of the references are listed.Heterochromatin protein (HP)1γ is not only in the nucleus but also in the cytoplasm interacting with actin in both cell compartments
Nancy L. Charo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer
Juliet E. Wolford et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Hyun-Wook Ryu et al.
CANCER LETTERS (2017)
Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3
Arno F. Alpi et al.
BIOCHEMICAL JOURNAL (2016)
Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes
Haruka Nishida et al.
JOURNAL OF CONTROLLED RELEASE (2016)
S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis
Sang Ah Yi et al.
MOLECULAR CELL (2016)
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Denise Martinez-Zapien et al.
NATURE (2016)
Heterochromatin Protein HP1γ Promotes Colorectal Cancer Progression and Is Regulated by miR-30a
Ming Liu et al.
CANCER RESEARCH (2015)
The demographics of the ubiquitin system
Michael J. Clague et al.
TRENDS IN CELL BIOLOGY (2015)
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Zheng Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
Edward M. Kennedy et al.
JOURNAL OF VIROLOGY (2014)
Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes
Jiansong Zhou et al.
ANTIVIRAL RESEARCH (2013)
Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer
Momoe Itsumi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy
Jae Duk Choi et al.
NUCLEIC ACIDS RESEARCH (2012)
Characterization of KRAS Rearrangements in Metastatic Prostate Cancer
Xiao-Song Wang et al.
CANCER DISCOVERY (2011)
Rescue of p53 Function by Small-Molecule RITA in Cervical Carcinoma by Blocking E6-Mediated Degradation
Carolyn Ying Zhao et al.
CANCER RESEARCH (2010)
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study
David H. Moore et al.
GYNECOLOGIC ONCOLOGY (2010)
Human POGZ modulates dissociation of HP1α from mitotic chromosome arms through Aurora B activation
Ryu-Suke Nozawa et al.
NATURE CELL BIOLOGY (2010)
Heterochromatin protein 1α: a hallmark of cell proliferation relevant to clinical oncology
Leanne De Koning et al.
EMBO MOLECULAR MEDICINE (2009)
The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Pauline J. Van der Watt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Structural basis for leucine-rich nuclear export signal recognition by CRM1
Xiuhua Dong et al.
NATURE (2009)
Linking Heterochromatin Protein 1 (HP1) to cancer progression
George K. Dialynas et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Dynamic changes in localization of chromobox (CBX) family members during the maternal to embryonic transition
Nancy T. Ruddock-D'Cruz et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2008)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Heterochromatin and its relationship to cell senescence and cancer therapy
Rugang Zhang et al.
CELL CYCLE (2007)
Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists
Riku Koivusalo et al.
CANCER RESEARCH (2006)
Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein
M. Vogt et al.
ONCOGENE (2006)
Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus
Norio Iizuka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53
D Stewart et al.
JOURNAL OF VIROLOGY (2005)
Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways
LG Le Roux et al.
JOURNAL OF VIROLOGY (2003)
Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail
SA Jacobs et al.
SCIENCE (2002)
Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9
PR Nielsen et al.
NATURE (2002)
Ubiquitin and malignant transformation of oral mucosa
LHH Cheng
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2001)
Rb targets histone H3 methylation and HP1 to promoters
SJ Nielsen et al.
NATURE (2001)
Heterochromatin formation in mammalian cells: Interaction between histones and HP1 proteins
AL Nielsen et al.
MOLECULAR CELL (2001)
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
AJ Bannister et al.
NATURE (2001)
Activation of p53 in cervical carcinoma cells by small molecules
S Hietanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Dimerisation of a chrome shadow domain and distinctions from the chromodomain as revealed by structural analysis
NP Cowieson et al.
CURRENT BIOLOGY (2000)
The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chrome domain dimer
SV Brasher et al.
EMBO JOURNAL (2000)